FDANews
FDAnews Drug Daily Bulletin

FDA Moves Against Internet Drug Retailers

Sept. 25, 2017

The FDA has cracked down on a host of operators peddling prescription drugs online, claiming the vendors are selling the drugs without a prescription, or marketing the drugs in a way that is not approved by the agency, or both.

The FDA cited 13 marketers in a batch of warning letters dated Sept. 19, in each case basing the action on a review of numerous web sites advertising the products. No physical addresses for the operators were included in the letters.

The letters, with the alleged violations, were sent to:

  • GlavMed, Medicina Mexico, MediPK, PharmCash, Pharmempire, Rx-Partners and Worldwide Drug Store, all for selling prescription drugs without requiring prescriptions and for selling the unapproved medication oral chloramphenicol.
  • 247Med, Bulk2USA and MyRXCash, all for selling unapproved versions of the opioid tramadol.
  • American Pharmacy Group, for selling an unapproved formulation of acetaminophen and the opioid hydrocodone.
  • CanAmerica Global, for selling injectable epinephrine under the unapproved name Allerject.
  • HA Stores, for selling the opioid roxicodone in an unapproved version called Roxicontin, and for selling the obesity treatment Slimall (sibutramine).

View today's stories